Boughton Soleil's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Jun 3, 2024
- Accession no.
- 0001773751-24-000156
- Filed
- Jun 3, 2024
- Trade date
- May 30, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.66M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boughton SoleilCIK 0001837817 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Class A Common Stock | MOption exerciseAcquired | +129,667 | $5.01 | +$649,631.67 | 286,522 | Direct | |
| May 30, 2024 | Class A Common Stock | SSaleDisposed | −114,460 | $20.47F2 | −$2,342,996.2 | 172,062 | Direct | |
| May 30, 2024 | Class A Common Stock | SSaleDisposed | −15,207 | $21.17F3 | −$321,932.19 | 156,855 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Class A Common Stock | MOption exerciseDisposed | −129,667 | $0.00 | $0 | 834,409 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.